Javier T. Solera
@jtsolera
Transplant and Oncohematology Infectious Diseases.
ID: 1517320979474694149
22-04-2022 01:55:06
60 Tweet
193 Followers
235 Following
Check out our last article in American Journal of Transplantation Short‐course Early Outpatient Remdesivir Prevents Severe Disease due to COVID‐19 in Organ Transplant Recipients During the Omicron BA.2 Wave onlinelibrary.wiley.com/doi/10.1111/aj… Deepali Kumar Atul Humar Ajmera Transplant Centre UHN
1/2 September 2022 American Society of Transplantation (AST) Infectious Diseases Community of Practice - AST Short-course Early Outpatient Remdesivir Prevents Severe Disease due to COVID-19 in Organ Transplant Recipients During the Omicron BA.2 Wave onlinelibrary.wiley.com/doi/abs/10.111…
In transplant recipients #Tixagevimab/#cilgavimab increased the neutralization against #Omicron BA.4/5, but had no effect on BQ.1.1 and XBB.1.5. Check our new article in The Lancet Infectious Diseases Deepali Kumar, Atul Humar, Victor Ferreira, PhD 🇨🇦🇵🇹, Ajmera Transplant Centre UHN #IDTwitter thelancet.com/journals/lanin…
Happy to share our research about outcomes of COVID-19 in solid organ transplant recipients at the 4th Fred Hutchinson Cancer Center #IDSymp23. Ajmera Transplant Centre UHN Deepali Kumar Atul Humar
Happy to share our research about clinical outcomes and immune response to different SARS-CoV-2 variants at the Second Ajmera Research Day. Ajmera Transplant Centre UHN Deepali Kumar Atul Humar Victor Ferreira, PhD 🇨🇦🇵🇹
In this propensity score matching analysis, we showed that COVID-19 reinfections in solid organ transplant recipients show a trend to better outcomes than the first infection. #ATC2023 Deepali Kumar Atul Humar Tori Hall Tina Marinelli Ajmera Transplant Centre UHN
Such an honour to celebrate Deepali Kumar American Society of Transplantation (AST) presidency with Ajmera Transplant Centre UHN colleagues Tori Hall Victor Ferreira, PhD 🇨🇦🇵🇹 Javier T. Solera AmericanTransplantCongress
Is it time to change the recommendations? Bivalent vaccine did not impact the immunity against current circulating COVID-19 variants in Immunocompromissed. Check our last article in The Lancet Infectious Diseases Deepali Kumar Victor Ferreira, PhD 🇨🇦🇵🇹 Atul Humar Ajmera Transplant Centre UHN thelancet.com/journals/lanin…
Excited to share the latest from the PREVenT-COVID study: Immunogenicity and Safety of Booster SARS-CoV-2 mRNA Vaccine Dose in Allogeneic Hematopoietic Stem Cell Transplant Recipients. Congrats to Ankit, Javier T. Solera, @transplant_ID and all co-authors! sciencedirect.com/science/articl…
Happy to be invited to talk about COVID-19 in SOT by the amazing team of the Miami Transplant Institute Yoichiro Natori Rodrigo Vianna
Congrats Javier T. Solera on leading this important work. Reassuring for SOTr and other immunocompromised patients. #Covid -19 reinfection associated with less severe outcomes. Tina Marinelli Ajmera Transplant Centre UHN Transplantation Atul Humar Deepali Kumar journals.lww.com/transplantjour…
Proud of our transplant team representing Ajmera Transplant Centre at CEOT2024! Ajmera Transplant Centre UHN Atul Humar Marcelo Cypel Mamatha Bhat American Society of Transplantation (AST)
In a large prospective cohort of 1,975 SOT recipientes, we showed that early treatment and ≥3 vaccine doses were associated with reduced severity. Lung tx was associated with worse outcomes Deepali Kumar Tina Marinelli Tori Hall Mittal Ankit 👨⚕️ doi.org/10.1016/j.ajt.…
Great study by Dr.Poramed Winichakoon, Hanan.Albasti. TxID, Javier T. Solera from UHN showing the characteristics and outcome of Pneumocystis Pneumonia in immunocompromised patients.#ATC2024Philly@UHNTransplant #TxID Infectious Diseases Community of Practice - AST